Expedia ( EXPE) estimates, target boosted at Credit Suisse. Shares of EXPE now seen reaching $60, according to Credit Suisse. Estimates also upped, given a higher realized conversion rate. Neutral rating. Fortinet ( FTNT) numbers lowered at Jefferies. Shares of FTNT now seen reaching $26, Jefferies said. Estimates also lowered on soft third quarter. Hold rating. Goldman Sachs ( GS) estimates raised at UBS through 2012, UBS said. Focus on capital returns to remain on share buybacks. Neutral rating and $125 price target. IBM ( IBM) estimates, target cut at BMO. IBM estimates were reduced through 2013, BMO Capital said. Company is seeing lower market demand. Market Perform rating and new $218 price target. IBM estimates trimmed at Citigroup. IBM estimates lowered through 2013, Citigroup said. FX headwinds and softer economy. $250 price target and Buy rating. Intel ( INTC) numbers cut at UBS. Shares of INTC now seen reaching $29, UBS said. Estimates also lowered on expected lower server processor growth, gross margin. Intel numbers lowered at Jefferies. Shares of INTC now seen reaching $24, Jefferies said. Estimates also lowered on slower growth, lower margins. Hold rating. Kroger ( KR) estimates, target raised at Guggenheim. Shares of KR now seen reaching $31, according to Guggenheim. Estimates also increased, given the company's new guidance. Buy rating. PNC Financial ( PNC) numbers reduced at BMO. Shares of PNC now seen reaching $68, according to BMO Capital. Estimates also cut, given a lower realized net interest margin. Market Perform rating. PNC Financial Services numbers lowered at Jefferies. Shares of PNC now seen reaching $72, Jefferies said. Estimates also lowered on limited catalysts. Buy rating. Regeneron ( REGN) estimates, target raised at BofA/Merrill. Shares of REGN now seen reaching $190, according to Bank of America/Merrill Lynch said. Estimates also increased, given higher expected Eylea growth. Buy rating. UnitedHealth ( UNH) estimates, target upped at BMO. UNH estimates were boosted through 2013, BMO Capital said. Company is seeing solid momentum across the board. Outperform rating and new $70 price target. Xerox ( XRX) estimates, target increased at BMO. XRX estimates were raised through 2013, BMO Capital said. Company is keeping a tight lid on costs and buying back more stock. Market Perform rating. >To submit a news tip, email: email@example.com.